当前位置: 首页 > 新闻资讯 > 产品文献 > "酶免"产品文献：Terazosin, a repurposed GPR119 agonist, ameliorates mitophagy and β-cell function in NAFPD by inhibiting MST1-Foxo3a signaling pathway

"酶免"产品文献：Terazosin, a repurposed GPR119 agonist, ameliorates mitophagy and β-cell function in NAFPD by inhibiting MST1-Foxo3a signaling pathway

酶免官方商城 / 2026-02-25

文献标题

Terazosin, a repurposed GPR119 agonist, ameliorates mitophagy and β-cell function in NAFPD by inhibiting MST1-Foxo3a signaling pathway

文献作者

Yi Yang、Chenglei Zhang、Jiarui Li、Lijuan Wang、Jie Ma、Xin Li

发表时间

2024年06月14日

文献影响因子

使用的酶免科研试剂盒产品名称

小鼠胰岛素（INS）ELISA科研试剂盒

下一篇:"酶免"产品文献：Nicotinamide Alleviates Synergistic Impairment of Intestinal Barrier Caused by MC-LR and NaNO2 Coexposure
上一篇:"酶免"产品文献：Associations of Gut and Circulating Microbiota with Circulating Vitamin D3, Type I Interferon, and Systemic Inflammation in Chronic Spontaneous Urticaria Patients

全部产品分类

浏览历史

"酶免"产品文献：Terazosin, a repurposed GPR119 agonist, ameliorates mitophagy and β-cell function in NAFPD by inhibiting MST1-Foxo3a signaling pathway